120 related articles for article (PubMed ID: 33902927)
21. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.
LeBlanc RE; Barton DT; Li Z; Angeles CV; Ernstoff MS; Bagley E; Wimmer D; Wong SL; Barth RJ; Shirai K; Yan S
Am J Surg Pathol; 2019 Jun; 43(6):755-765. PubMed ID: 31091203
[TBL] [Abstract][Full Text] [Related]
22. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
Woeste MR; McMasters KM; Egger ME
J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
[TBL] [Abstract][Full Text] [Related]
23. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
24. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
[TBL] [Abstract][Full Text] [Related]
25. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
[TBL] [Abstract][Full Text] [Related]
26. [Sentinel lymph node biopsy necessary in melanoma patients].
Nieweg OE; Hoekstra HJ
Ned Tijdschr Geneeskd; 2014; 158():A8194. PubMed ID: 25370951
[TBL] [Abstract][Full Text] [Related]
27. Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.
Gonzalez AB; Jakub JW; Harmsen WS; Suman VJ; Markovic SN
J Am Coll Surg; 2016 Jul; 223(1):77-85.e1. PubMed ID: 27118347
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimeters.
Caracò C; Celentano E; Lastoria S; Botti G; Ascierto PA; Mozzillo N
Ann Surg Oncol; 2004 Mar; 11(3 Suppl):198S-202S. PubMed ID: 15023751
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
30. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.
Doepker MP; Thompson ZJ; Harb JN; Messina JL; Puleo CA; Egan KM; Sarnaik AA; Gonzalez RJ; Sondak VK; Zager JS
J Surg Oncol; 2016 Jan; 113(1):98-102. PubMed ID: 26661407
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
[TBL] [Abstract][Full Text] [Related]
32. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study.
Oude Ophuis CM; Verhoef C; Rutkowski P; Powell BW; van der Hage JA; van Leeuwen PA; Voit CA; Testori A; Robert C; Hoekstra HJ; Grünhagen DJ; Eggermont AM; van Akkooi AC
Eur J Surg Oncol; 2016 Dec; 42(12):1906-1913. PubMed ID: 27266406
[TBL] [Abstract][Full Text] [Related]
33. Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?
Han D; Han G; Morrison S; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Sondak VK; Zager JS
Surgery; 2020 Sep; 168(3):518-526. PubMed ID: 32669204
[TBL] [Abstract][Full Text] [Related]
34. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma.
Doting MH; Hoekstra HJ; Plukker JT; Piers DA; Jager PL; Tiebosch AT; Vermey A; Schraffordt Koops H
Eur J Surg Oncol; 2002 Sep; 28(6):673-8. PubMed ID: 12359207
[TBL] [Abstract][Full Text] [Related]
35. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
[TBL] [Abstract][Full Text] [Related]
36. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
37. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
[TBL] [Abstract][Full Text] [Related]
38. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
39. The sentinel node biopsy has come of age.
McGregor JM
Br J Dermatol; 2019 Aug; 181(2):423. PubMed ID: 30724352
[No Abstract] [Full Text] [Related]
40. Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma.
Kim J; Sun Z; Gulack BC; Adam MA; Mosca PJ; Rice HE; Tracy ET
J Pediatr Surg; 2016 Jun; 51(6):986-90. PubMed ID: 27041229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
